Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis

Key facts

Sponsor

Mashhad University of Medical Sciences

Principal Investigator

Zahra Rezaieyazdi, MD, MD

Rheumatic Diseases Research Center, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Intervention

Leflunomide(drug)

Enrollment

30 enrolled

Eligibility

2-19 years · All sexes

Timeline

2013 – 2014

Study locations (1)

• Mashhad, Khorasan Razavi, Iran

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07553182
  OLE Study With Filgotinib in JIA
  Alfasigma S.p.A.
• ENROLLING BY INVITATIONPHASE3NCT07386587
  Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
  University of Child Health Sciences and Children's Hospital, Lahore
• RECRUITINGPHASE3NCT06654882
  Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
  Duke University
• RECRUITINGNCT07243782
  Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
  Novartis Pharmaceuticals
• RECRUITINGNANCT07217782
  Pain in Juvenile Arthritis
  Washington University School of Medicine
• RECRUITINGNCT07185750
  Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
  Hacettepe University
• RECRUITINGNCT06718569
  Pain in Inflammatory Joint Diseases
  Diakonhjemmet Hospital
• RECRUITINGNANCT07234747
  Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
  Istanbul University - Cerrahpasa

See all trials for Juvenile idiopathic arthritis →